214 related articles for article (PubMed ID: 29130507)
1. Neurofascin-155 IGG4 Neuropathy: Pathophysiological Insights, Spectrum of Clinical Severity and Response To treatment.
Garg N; Park SB; Yiannikas C; Vucic S; Howells J; Noto YI; Mathey EK; Pollard JD; Kiernan MC
Muscle Nerve; 2018 May; 57(5):848-851. PubMed ID: 29130507
[TBL] [Abstract][Full Text] [Related]
2. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
3. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy.
Devaux JJ; Miura Y; Fukami Y; Inoue T; Manso C; Belghazi M; Sekiguchi K; Kokubun N; Ichikawa H; Wong AH; Yuki N
Neurology; 2016 Mar; 86(9):800-7. PubMed ID: 26843559
[TBL] [Abstract][Full Text] [Related]
4. IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: Clinical significance and diagnostic utility of a conventional assay.
Kadoya M; Kaida K; Koike H; Takazaki H; Ogata H; Moriguchi K; Shimizu J; Nagata E; Takizawa S; Chiba A; Yamasaki R; Kira JI; Sobue G; Ikewaki K
J Neuroimmunol; 2016 Dec; 301():16-22. PubMed ID: 27852440
[TBL] [Abstract][Full Text] [Related]
5. Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta-analysis.
Hu W; Xin Y; He Z; Zhao Y
Brain Behav; 2018 Oct; 8(10):e01115. PubMed ID: 30240176
[TBL] [Abstract][Full Text] [Related]
6. Parallel fluctuation of anti-neurofascin 155 antibody levels with clinico-electrophysiological findings in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
Fujita A; Ogata H; Yamasaki R; Matsushita T; Kira JI
J Neurol Sci; 2018 Jan; 384():107-112. PubMed ID: 29249367
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
Delmont E; Manso C; Querol L; Cortese A; Berardinelli A; Lozza A; Belghazi M; Malissart P; Labauge P; Taieb G; Yuki N; Illa I; Attarian S; Devaux JJ
Brain; 2017 Jul; 140(7):1851-1858. PubMed ID: 28575198
[TBL] [Abstract][Full Text] [Related]
8. ELectron microscopic abnormality and therapeutic efficacy in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin155 immunoglobulin G4 antibody.
Kuwahara M; Suzuki H; Oka N; Ogata H; Yanagimoto S; Sadakane S; Fukumoto Y; Yamana M; Yuhara Y; Yoshikawa K; Morikawa M; Kawai S; Okazaki M; Tsujimoto T; Kira JI; Kusunoki S
Muscle Nerve; 2018 Mar; 57(3):498-502. PubMed ID: 28796305
[TBL] [Abstract][Full Text] [Related]
9. Teaching Neuro
Franques J; Chapon F; Devaux J; Mathis S
Neurology; 2017 Feb; 88(7):e52. PubMed ID: 28193760
[No Abstract] [Full Text] [Related]
10. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
[TBL] [Abstract][Full Text] [Related]
11. Tongue tremor in neurofascin-155 IgG4 seropositive chronic inflammatory polyradiculoneuropathy.
Briani C; Salvalaggio A; Ruiz M; Cacciavillani M; Rinaldi F; Callegari I; Gasparotti R; Franciotta D
J Neuroimmunol; 2019 May; 330():178-180. PubMed ID: 30713112
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype.
Cortese A; Lombardi R; Briani C; Callegari I; Benedetti L; Manganelli F; Luigetti M; Ferrari S; Clerici AM; Marfia GA; Rigamonti A; Carpo M; Fazio R; Corbo M; Mazzeo A; Giannini F; Cosentino G; Zardini E; Currò R; Gastaldi M; Vegezzi E; Alfonsi E; Berardinelli A; Kouton L; Manso C; Giannotta C; Doneddu P; Dacci P; Piccolo L; Ruiz M; Salvalaggio A; De Michelis C; Spina E; Topa A; Bisogni G; Romano A; Mariotto S; Mataluni G; Cerri F; Stancanelli C; Sabatelli M; Schenone A; Marchioni E; Lauria G; Nobile-Orazio E; Devaux J; Franciotta D
Neurol Neuroimmunol Neuroinflamm; 2020 Jan; 7(1):. PubMed ID: 31753915
[TBL] [Abstract][Full Text] [Related]
13. Optic, trigeminal, and facial neuropathy related to anti-neurofascin 155 antibody.
Ogata H; Zhang X; Inamizu S; Yamashita KI; Yamasaki R; Matsushita T; Isobe N; Hiwatashi A; Tobimatsu S; Kira JI
Ann Clin Transl Neurol; 2020 Nov; 7(11):2297-2309. PubMed ID: 33080117
[TBL] [Abstract][Full Text] [Related]
14. Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes.
Shelly S; Klein CJ; Dyck PJB; Paul P; Mauermann ML; Berini SE; Howe B; Fryer JP; Basal E; Bakri HM; Laughlin RS; McKeon A; Pittock SJ; Mills J; Dubey D
Neurology; 2021 Dec; 97(24):e2392-e2403. PubMed ID: 34635556
[TBL] [Abstract][Full Text] [Related]
15. Acute-onset chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 antibodies and bilateral facial nerve enhancement.
Caetano A; Ladeira F; Fernandes M; Pires P; Medeiros E
J Neuroimmunol; 2019 Nov; 336():577026. PubMed ID: 31450157
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological features of chronic inflammatory demyelinating polyradiculoneuropathy associated with IgG4 antibodies targeting neurofascin 155 or contactin 1 glycoproteins.
Kouton L; Boucraut J; Devaux J; Rajabally YA; Adams D; Antoine JC; Bourdain F; Brodovitch A; Camdessanché JP; Cauquil C; Ciron J; Dubard T; Echaniz-Laguna A; Grapperon AM; Juntas-Morales R; Kremer L; Kuntzer T; Labeyrie C; Lanfranco L; Léger JM; Maisonobe T; Mavroudakis N; Mecharles-Darrigol S; Merle P; Noury JB; Rouaud V; Tard C; Théaudin M; Vallat JM; Viala K; Attarian S; Delmont E
Clin Neurophysiol; 2020 Apr; 131(4):921-927. PubMed ID: 32078921
[TBL] [Abstract][Full Text] [Related]
17. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
[TBL] [Abstract][Full Text] [Related]
18. Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies.
Wang W; Liu L; Zhang M; Yang R; Liu D; Yang S; Meng Q
Front Immunol; 2022; 13():1028282. PubMed ID: 36248836
[TBL] [Abstract][Full Text] [Related]
19. Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.
Burnor E; Yang L; Zhou H; Patterson KR; Quinn C; Reilly MM; Rossor AM; Scherer SS; Lancaster E
Neurology; 2018 Jan; 90(1):e31-e38. PubMed ID: 29187518
[TBL] [Abstract][Full Text] [Related]
20. Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti-Neurofascin-155 Antibodies.
Bailly L; Mongin M; Delorme C; Apartis E; Saheb S; Viala K; Roze E
Tremor Other Hyperkinet Mov (N Y); 2018; 8():606. PubMed ID: 30619643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
